Exagen Inc (XGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -12,038 | -8,012 | N/A | N/A |
| Depreciation Amortization | 1,282 | 1,318 | N/A | N/A |
| Income taxes - deferred | 0 | 31 | N/A | N/A |
| Accounts receivable | 237 | -2,262 | N/A | N/A |
| Accounts payable and accrued liabilities | 528 | -824 | N/A | N/A |
| Other Working Capital | 174 | -3,591 | N/A | N/A |
| Other Operating Activity | 106 | 4,039 | 0 | 0 |
| Operating Cash Flow | $-9,711 | $-9,301 | $N/A | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -103 | -199 | N/A | N/A |
| Investing Cash Flow | $-103 | $-199 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 4,995 | N/A | N/A |
| Debt Repayment | -138 | -38 | N/A | N/A |
| Common Stock Issued | 50,448 | N/A | N/A | N/A |
| Other Financing Activity | 18,424 | 6,466 | 0 | 0 |
| Financing Cash Flow | $68,734 | $11,423 | $N/A | $N/A |
| Beginning Cash Position | 13,264 | 11,341 | N/A | N/A |
| End Cash Position | 72,184 | 13,264 | N/A | N/A |
| Net Cash Flow | $58,920 | $1,923 | $N/A | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -9,711 | -9,301 | N/A | N/A |
| Capital Expenditure | -403 | -199 | N/A | N/A |
| Free Cash Flow | -10,114 | -9,500 | 0 | 0 |